As of June 16, 2025, Cronos Group Inc (CRON.TO) reports a Graham Number of 2.57.
Graham Number calculates a stock's intrinsic value based on earnings and book value, aiding in spotting undervalued investments.
Historical Trend of Cronos Group Inc's Graham Number
Over recent years, Cronos Group Inc's Graham Number has shown significant volatility. The table below summarizes the historical values:
| Date | Graham Number |
|---|---|
| 2024-12-31 | 2.57 |
| 2023-12-31 | 17.58 |
| 2022-12-31 | 0.14 |
| 2021-12-31 | 0.01 |
This slight upward trend highlights how Cronos Group Inc manages its intrinsic value calculation based on earnings per share and book value over time.
Comparing Cronos Group Inc's Graham Number to Peers
To better understand Cronos Group Inc's position, it's useful to compare its Graham Number against industry peers. Below are selected comparisons:
| Company | Graham Number |
|---|---|
| Cronos Group Inc (CRON.TO) | 2.57 |
| Theravance Biopharma Inc (TBPH) | 59.12 |
| Taro Pharmaceutical Industries Ltd (TARO) | 39.23 |
| Amphastar Pharmaceuticals Inc (AMPH) | 34.39 |
| TherapeuticsMD Inc (TXMD) | 28.11 |
| Harmony Biosciences Holdings Inc (HRMY) | 25.54 |
Compared to its competitors, Cronos Group Inc's Graham Number is among the lowest compared to peers, which may indicate relative fundamental weakness by Graham's criteria.